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In the past decade there has been a tremendous growth of
information in our understanding of the mechanisms of hy-
pertension, new pharmacologic approaches to the treatment
of hypertension and the transfer of this information into
large-scale treatment programs. This has placed a remark-
able demand on the practicing physician to assimilate the
complex interrelation of the many factors that control arterial
pressure and the mechanisms of a host of new antihyper-
tensive compounds. Since 1972 the cardiologist has seen
many drugs introduced for the treatment of patients with
hypertension: the beta-adrenergic receptor blocking drugs,
the calcium slow channel entrance blocking drugs, the an-
giotensin-converting enzyme inhibitors, angiotensin II re-
ceptor blocking drugs, new potassium-preserving diuretic
agents and a myriad of specific compounds that have unique
differences from other members of their class.
It is of great concern that the hypertensive patient with
specific cardiovascular problems not be lost in the efforts
to assimilate new information and implement simplified
therapy for major population groups. Clearly, the patient
with major cardiovascular complications also having high
blood pressure requires an individualized concern for his
management; this seminar provides that approach.
We have addressed the problem of hypertension in four
major cardiovascular catastrophic illnesses. The approach
to the treatment of heart failure has been radically reeval-
uated in the past several years. Although the concept of
"unloading the heart" has been preached by "hyperten-
sionologists" for 3 decades, the feasibility and popularity
of this concept has recently taken on additional meaning for
the practicing cardiologist. Novel means for providing this
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approach to the treatment of heart failure have been offered
not only by clinical vasodilator drugs but also by the new
angiotensin-converting enzyme inhibitors. Haralambos Gavras
of Boston University discusses the problem of heart failure
in hypertension, taking into consideration those newer phar-
macologic advances and considerations.
With regard to hypertension and stroke, the paper by
Michael D. Cressman and Ray W. Gifford, Jr. of the Cleve-
land Clinic reflects considerable practical experience in the
presentation and implementation of new concepts in the
practice of cardiovascular medicine as they relate to the
patient with systolic hypertension and with stroke. Truly,
this is one of the most concise and well documented reviews
of this subject.
Ischemic heart disease is a major compounding problem
of hypertension. The studies from Framingham have sug-
gested that the chances of acute myocardial infarction and
sudden death are enhanced by a state of elevated arterial
pressure. Conversely, the management of the patient with
myocardial infarction who has preexisting hypertension re-
quires a more immediate therapeutic concept, not only of
preventing a first and second infarction by antihypertensive
therapy but of treating the hypertension in a patient with an
existing acute infarction. Francis G. Dunn, cardiologist in
the Division of Hypertensive Diseases of Ochsner Clinic,
addresses this subject.
One of the major emergent and acute cardiovascular
problems is that of dissecting aneurysm in the patient with
an elevated arterial pressure. The experience of the Mayo
Clinic with this problem has been extensive, but experience
in the general scientific literature is at best fragmentary.
John A. Spittell, Jr. of Mayo has collated his considerable
personal experience with the more general experiences from
published reports into an excellent discussion of the patient
with arterial aneurysm and hypertension.
We hope that the excitement engendered by these authors
in our review will be similarly experienced by the readers.
We therefore heartily recommend this seminar for your
reading.
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